ZEB1 and histiocytic sarcoma: Additionally, regulating these molecules' expression, such as developing drugs or therapies to upregulate miR‐431‐5p or inhibit ZEB1 activity, may offer novel strategies for personalized medicine and provide effective approaches for treating HS.